about
TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activityTRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2ALentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitroThe interferon-inducible antiviral protein Daxx is not essential for interferon-mediated protection against avian sarcoma virus.Interferon-stimulated genes: a complex web of host defenses.Upregulation of innate antiviral restricting factor expression in the cord blood and decidual tissue of HIV-infected mothers.In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 geneInterferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patientsRegulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells.Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation.TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity.Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway.p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity.Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human MacrophagesThe TRIMendous Role of TRIMs in Virus-Host Interactions.Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications.Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.
P2860
Q24301176-17FC7740-CEC2-4745-9759-5A6D307A1ED3Q27468655-E0528B42-045B-4D1B-A83A-87AB0513B63CQ33598835-DB548CCE-96BB-4C2F-8815-0E4738065AFDQ33726203-84C33DCC-DBF8-4C58-AD12-68D016B1AD21Q34405609-9E251F7D-9B77-454A-8AD5-7AD2BC380EF8Q35075884-3FF8F150-72DE-4DB3-B3CD-187CDE34134DQ35199204-8EBC3D48-1929-41BF-B378-6C07C5CA4C0FQ36459126-9E0DA9DD-415C-431F-B87E-29A831279FAFQ37222827-6EF11E7A-581D-4C34-9E5B-D4A4F8F1A40DQ37230823-4DEF2EB2-E9DE-44BD-8FA1-0E680AD1C109Q37579656-44464F96-DD89-4F28-B12D-9DFA8944BE0EQ37648812-E3F204E9-4036-4E76-B3DB-8480BF5DAA0BQ37713931-82590275-1FB1-42E0-B6D6-BCA0B4EBA9DFQ38170892-085212E8-0F30-45ED-B811-B7EEE17088C1Q38692134-E4568784-61FB-44A6-A1ED-9002519EBA90Q39152504-FC558C8B-4C88-4510-8F8D-2BCE2541A11FQ39530544-3F57220F-84B3-47DC-98CB-0CB8A5DBE783Q40075519-750A4FCA-8676-4BDA-9059-E70514A6BC62Q40181655-929D7ADC-29BF-4F38-B76D-4F35C7C6CE8CQ40533140-32DC2AF4-EC31-4E8E-B090-DE0A959F0AFAQ41575072-D5FA9EDF-C83D-41C5-832C-C61B940E337EQ42215059-20DC2148-D861-4FA8-ADCD-C0D4D727E305Q42369135-E026E121-D789-4602-81B4-E19B703AFE5AQ47120902-58926B22-4F78-4E4E-BCDC-1640C78C0DC6
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
TRIM22: A Diverse and Dynamic Antiviral Protein
@ast
TRIM22: A Diverse and Dynamic Antiviral Protein
@en
type
label
TRIM22: A Diverse and Dynamic Antiviral Protein
@ast
TRIM22: A Diverse and Dynamic Antiviral Protein
@en
prefLabel
TRIM22: A Diverse and Dynamic Antiviral Protein
@ast
TRIM22: A Diverse and Dynamic Antiviral Protein
@en
P2093
P2860
P356
P1476
TRIM22: A Diverse and Dynamic Antiviral Protein
@en
P2093
Clayton J Hattlmann
Jenna N Kelly
Stephen D Barr
P2860
P304
P356
10.1155/2012/153415
P577
2012-05-08T00:00:00Z